Empresa Biodel Inc Nasdaq
Acciones
US09064M2044
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ronald Cooper
CEO | Chief Executive Officer | 61 | 01/06/15 |
Founder | 60 | 08/12/03 | |
President | 57 | 02/03/23 | |
Joan Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 13/04/21 |
Paul Streck
CTO | Chief Tech/Sci/R&D Officer | 60 | 19/12/22 |
Heather White
CTO | Chief Tech/Sci/R&D Officer | - | 02/03/23 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Corporate Secretary | - | 02/03/23 | |
Michelle Graham
HRO | Human Resources Officer | 57 | 04/11/19 |
Muffy Carter
LAW | General Counsel | 71 | 29/11/16 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 55 | 02/03/23 | |
Director/Board Member | 62 | 02/03/23 | |
Ronald Cooper
CEO | Chief Executive Officer | 61 | 01/06/15 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 20 709 043 | 18 650 831 ( 90,06 %) | 7 760 ( 0,0375 %) | 90,06 % |
Información de la empresa
Albireo Pharma, Inc.
53 State Street 19th Floor
02109, Boston
+857 254 5555
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+8,63 % | 114 mil M | |
+13,17 % | 107 mil M | |
-12,76 % | 22,22 mil M | |
-2,85 % | 21,28 mil M | |
-7,19 % | 17,51 mil M | |
-39,93 % | 17,17 mil M | |
+6,67 % | 14,14 mil M | |
+33,90 % | 12,2 mil M | |
-28,60 % | 7830,9 M |